Fellow humans with aged prostate glands...
|
| Post date: 2022-11-27 18:32:03 |
| Views: 143 |
I've been prescribed Tamsulosin for the usual reasons. I'm finding it difficult to figure out what time of day to take it. Does the time actually matter, in terms of efficacy? Have you been taking it *not* in the morning, and found it to work OK?
The guidance seems to vary widely. The prevailing wisdom (?) seems to be to take it in the morning, and/or "30 minutes after the same meal every day". I'd like to take it at night, per the side-effect of sleepiness. Fighting daytime sleepiness etc. is already a struggle due to other medications I take (which I cannot not take); I have zero appetite for making it worse by adding in something new.
Also, WTF is with this "take 30 minutes after a meal" nonsense? Or is it indeed sensible and recommended that one wait 30 minutes, and not longer than 30 minutes, after a meal, to take this stuff?
Bonus Round: anyone had success using other supplements (e.g. saw palmetto, corn silk...) in addition to, if not in lieu of, taking Tamsulosin? I have no principled opposition to taking it, but the common side effects of sleepiness and lower back pain are two things I can really use less of already.
Thank you! |
| Please click Here to read the full story. |
| |
| Other Top and Latest Questions: |
Trump condemns racist video showing Obamas as apes after removing it, but says he won't apologize
|
First the quarter zip, now a '401(k) mullet' — what Gen Z trends say about the economy
|
I've studied over 200 kids—the happiest ones have parents who do 6 things with them before bedtime
|
Epstein files: UK PM Starmer's top aide McSweeney quits over Mandelson scandal
|
Elon Musk wants to be a trillionaire — here's how SpaceX may get him there
|
NFL plans to have discussions with partners outside of core media for live games, media chief says
|
U.S. plans initial payment towards billions owed to the UN, envoy Waltz says
|
Kroger to name former Walmart exec Greg Foran as next CEO, WSJ reports
|
Goldman Sachs says this under-the-radar biotech play could more than double in value
|
Japan's Nikkei 225 skyrockets over 5% to hit record highs as Takaichi secures historic mandate
|